ResMed Inc. (RMD)
NYSE: RMD
· Real-Time Price · USD
283.95
-0.77 (-0.27%)
At close: Aug 15, 2025, 12:14 PM
ResMed Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 5.15B | 5.02B | 4.93B | 4.81B | 4.55B | 4.44B | 4.36B | 4.24B | 4.22B | 4.02B | 3.76B | 3.62B | 3.58B | 3.54B | 3.44B | 3.35B | 3.2B | 3.09B | 3.09B | 3.03B |
Cost of Revenue | 2.09B | 2.08B | 2.07B | 2.06B | 1.91B | 1.9B | 1.88B | 1.82B | 1.87B | 1.75B | 1.63B | 1.57B | 1.55B | 1.55B | 1.5B | 1.44B | 1.36B | 1.29B | 1.29B | 1.26B |
Gross Profit | 3.05B | 2.94B | 2.85B | 2.75B | 2.63B | 2.55B | 2.48B | 2.41B | 2.36B | 2.26B | 2.13B | 2.06B | 2.02B | 1.99B | 1.95B | 1.91B | 1.84B | 1.8B | 1.8B | 1.76B |
Operating Income | 1.69B | 1.61B | 1.56B | 1.42B | 1.32B | 1.21B | 1.14B | 1.15B | 1.13B | 1.11B | 1.05B | 1.01B | 1B | 986.53M | 975.69M | 948.69M | 903.67M | 885.28M | 879.36M | 855.45M |
Interest Income | 6.55M | 4.42M | 6.98M | 6.98M | 6.98M | 3.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59K | 114K | 246K | 363K | 559K | 620K | 690K |
Pretax Income | 1.68B | 1.58B | 1.53B | 1.38B | 1.26B | 1.18B | 1.1B | 1.11B | 1.1B | 1.06B | 999.89M | 963.49M | 960.48M | 961.6M | 953.29M | 926.6M | 883.66M | 856.54M | 830.2M | 798.36M |
Net Income | 1.4B | 1.31B | 1.25B | 1.11B | 1.02B | 958.38M | 890.39M | 906.5M | 897.56M | 862.95M | 809.47M | 786.3M | 779.44M | 779.47M | 521.98M | 499.74M | 474.5M | 457.24M | 698.86M | 679.9M |
Selling & General & Admin | 991.02M | 968.08M | 952.7M | 933.24M | 917.13M | 915.63M | 914.17M | 903.69M | 874.75M | 828.95M | 782.89M | 756.59M | 739.37M | 725.97M | 704.01M | 688.12M | 670.39M | 654.29M | 666.28M | 668.24M |
Research & Development | 331.28M | 325.7M | 318.83M | 311.34M | 307.52M | 304.81M | 304.17M | 300.16M | 287.64M | 273.82M | 264.18M | 256.81M | 253.58M | 249.13M | 238.27M | 230.7M | 225.28M | 217.93M | 213.44M | 208.44M |
Other Expenses | 47.3M | 33.34M | 22.45M | 87.21M | 88.28M | 111.57M | 123.76M | 65.93M | 61.4M | 46.02M | 41.56M | 31.32M | 31.08M | 30.88M | 30.59M | 39.22M | 39.75M | 40.27M | 41.1M | 33.29M |
Operating Expenses | 1.37B | 1.33B | 1.29B | 1.33B | 1.31B | 1.33B | 1.34B | 1.27B | 1.22B | 1.15B | 1.09B | 1.04B | 1.02B | 1.01B | 972.87M | 958.03M | 935.42M | 912.49M | 920.82M | 909.97M |
Interest Expense | 10.29M | 19.84M | 34.22M | 43.23M | 52.69M | 58.08M | 58.67M | 55.2M | 47.38M | 37.98M | 28.48M | 24.09M | 22.31M | 22.11M | 22.53M | 22.51M | 23.99M | 27.84M | 31.93M | 36.23M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.46B | 3.41B | 3.37B | 3.39B | 3.23B | 3.23B | 3.22B | 3.09B | 3.09B | 2.9B | 2.72B | 2.61B | 2.58B | 2.55B | 2.47B | 2.4B | 2.29B | 2.21B | 2.21B | 2.17B |
Income Tax Expense | 276.84M | 263.99M | 286.27M | 263.22M | 243.85M | 225.49M | 207.44M | 205.56M | 204.11M | 200M | 190.43M | 177.19M | 181.04M | 182.13M | 431.31M | 426.85M | 409.16M | 399.31M | 131.34M | 118.46M |
Shares Outstanding (Basic) | 146.47M | 146.72M | 146.86M | 146.86M | 146.91M | 146.96M | 147.13M | 147.07M | 147.01M | 146.91M | 146.7M | 146.43M | 146.36M | 146.24M | 145.99M | 145.68M | 145.6M | 145.34M | 145.25M | 144.9M |
Shares Outstanding (Diluted) | 147.04M | 147.22M | 147.6M | 147.6M | 147.53M | 147.45M | 147.54M | 147.49M | 147.55M | 147.4M | 147.41M | 147.13M | 147M | 146.96M | 147.04M | 146.86M | 146.54M | 145.51M | 146.42M | 146.1M |
EPS (Basic) | 9.55 | 8.95 | 8.50 | 7.57 | 6.94 | 6.51 | 6.05 | 6.16 | 6.11 | 5.88 | 5.52 | 5.37 | 5.33 | 5.34 | 3.58 | 3.44 | 3.27 | 3.16 | 4.83 | 4.70 |
EPS (Diluted) | 9.51 | 8.91 | 8.47 | 7.55 | 6.93 | 6.51 | 6.05 | 6.16 | 6.10 | 5.87 | 5.51 | 5.35 | 5.31 | 5.31 | 3.55 | 3.41 | 3.24 | 3.13 | 4.79 | 4.66 |
EBITDA | 1.92B | 1.81B | 1.77B | 1.69B | 1.59B | 1.51B | 1.43B | 1.37B | 1.35B | 1.31B | 1.24B | 1.2B | 1.19B | 1.18B | 1.17B | 1.15B | 1.1B | 1.08B | 1.08B | 1.03B |
EBIT | 1.69B | 1.6B | 1.55B | 1.47B | 1.37B | 1.29B | 1.22B | 1.16B | 1.15B | 1.12B | 1.05B | 1.01B | 1B | 986.53M | 975.69M | 957.37M | 912.35M | 892M | 886.08M | 844.66M |
Depreciation & Amortization | 235.81M | 216.28M | 219.01M | 216.48M | 216.21M | 216.65M | 214.8M | 206.97M | 197.56M | 187.37M | 186.19M | 190.26M | 193.84M | 194.51M | 190.79M | 189.25M | 191.52M | 191.35M | 189.93M | 187.34M |